-
Je něco špatně v tomto záznamu ?
Population pharmacokinetics of three alternative prophylactic antibiotics during cardiac surgery with extracorporeal circulation
P. Santavy, V. Kubickova, M. Sima, K. Urbanek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
35775358
DOI
10.5507/bp.2022.033
Knihovny.cz E-zdroje
- MeSH
- ampicilin MeSH
- antibakteriální látky terapeutické užití MeSH
- antibiotická profylaxe metody MeSH
- cefazolin * farmakokinetika terapeutické užití MeSH
- ciprofloxacin MeSH
- dospělí MeSH
- kardiochirurgické výkony * MeSH
- lidé MeSH
- mimotělní oběh MeSH
- prospektivní studie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: The aim of this pharmacokinetic study was to describe and quantify population pharmacokinetics of three antibiotics, cefazolin, ampicillin, and ciprofloxacin, used as antibacterial prophylaxis during cardiovascular surgery with the use of extracorporeal circulation (ECC). METHODS: Adult patients undergoing cardiac surgery with ECC were enrolled to this prospective, pharmacokinetic study. An intravenous bolus of 2 g of ampicillin, 2 g of cefazolin or 400 mg of ciprofloxacin was administered 60-30 min before surgery. Blood samples were collected at 15, 30, 45, 60, 120 and 180 min after the administration and at the end of the surgery. Plasma concentrations of the antibiotics were measured using HPLC methods. Serum concentration-time profiles were analyzed using nonlinear mixed-effects modeling approach. RESULTS: A total of 54 patients were enrolled into the study, 20 with ampicillin, 25 cefazolin and 9 ciprofloxacin. For all antibiotics, population pharmacokinetic models have been successfully developed. CONCLUSION: We identified estimated glomerular filtration rate (eGFR) as the main factor determining the achievement of the pharmacokinetic/pharmacodynamic (PK/PD) target in ampicillin or cefazolin and body weight in ciprofloxacin prophylaxis during cardiac surgery with ECC support.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23008947
- 003
- CZ-PrNML
- 005
- 20230802075201.0
- 007
- ta
- 008
- 230707s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2022.033 $2 doi
- 035 __
- $a (PubMed)35775358
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šantavý, Petr, $u Department of Cardiac Surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $d 1973- $7 xx0211055
- 245 10
- $a Population pharmacokinetics of three alternative prophylactic antibiotics during cardiac surgery with extracorporeal circulation / $c P. Santavy, V. Kubickova, M. Sima, K. Urbanek
- 520 9_
- $a AIMS: The aim of this pharmacokinetic study was to describe and quantify population pharmacokinetics of three antibiotics, cefazolin, ampicillin, and ciprofloxacin, used as antibacterial prophylaxis during cardiovascular surgery with the use of extracorporeal circulation (ECC). METHODS: Adult patients undergoing cardiac surgery with ECC were enrolled to this prospective, pharmacokinetic study. An intravenous bolus of 2 g of ampicillin, 2 g of cefazolin or 400 mg of ciprofloxacin was administered 60-30 min before surgery. Blood samples were collected at 15, 30, 45, 60, 120 and 180 min after the administration and at the end of the surgery. Plasma concentrations of the antibiotics were measured using HPLC methods. Serum concentration-time profiles were analyzed using nonlinear mixed-effects modeling approach. RESULTS: A total of 54 patients were enrolled into the study, 20 with ampicillin, 25 cefazolin and 9 ciprofloxacin. For all antibiotics, population pharmacokinetic models have been successfully developed. CONCLUSION: We identified estimated glomerular filtration rate (eGFR) as the main factor determining the achievement of the pharmacokinetic/pharmacodynamic (PK/PD) target in ampicillin or cefazolin and body weight in ciprofloxacin prophylaxis during cardiac surgery with ECC support.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a cefazolin $x farmakokinetika $x terapeutické užití $7 D002437
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a antibiotická profylaxe $x metody $7 D019072
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a ampicilin $7 D000667
- 650 _2
- $a ciprofloxacin $7 D002939
- 650 12
- $a kardiochirurgické výkony $7 D006348
- 650 _2
- $a mimotělní oběh $7 D005112
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kubíčková, Vendula $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $7 xx0258821
- 700 1_
- $a Šíma, Martin $u Department of Pharmacology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic $7 xx0222901
- 700 1_
- $a Urbánek, Karel, $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $d 1969- $7 xx0078289
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 2 (2023), s. 208-211
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35775358 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230802075157 $b ABA008
- 999 __
- $a ok $b bmc $g 1964365 $s 1195210
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 167 $c 2 $d 208-211 $e 20220629 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK198 $a Pubmed-20230707